| Date Filed | Type | Description |
| 10/04/2023 |
4
| Hawryluk Matthew (Director) has filed a Form 4 on Predictive Oncology Inc.|
Txns:
| Granted 1,875 shares
@ $0 |
|
| 07/05/2023 |
4
| Hawryluk Matthew (Director) has filed a Form 4 on Predictive Oncology Inc.|
Txns:
| Granted 2,675 shares
@ $0 |
|
| 04/05/2023 |
4
| Hawryluk Matthew (Director) has filed a Form 4 on Predictive Oncology Inc.|
Txns:
| Granted 18,360 shares
@ $0 |
|
| 02/06/2023 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 191,771 shares
@ $0 |
|
| 01/04/2023 |
4
| Hawryluk Matthew (Director) has filed a Form 4 on Predictive Oncology Inc.|
Txns:
| Granted 19,570 shares
@ $0 |
|
| 12/05/2022 |
4
| Hawryluk Matthew (Director) has filed a Form 4 on Predictive Oncology Inc.|
Txns:
| Granted 13,762 shares
@ $0 |
|
| 12/05/2022 |
3
| Hawryluk Matthew (Director) has filed a Form 3 on Predictive Oncology Inc. |
| 04/20/2022 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 21,612 shares
@ $0
Granted 129,675 options to buy
@ $5.46, valued at
$708k
|
|
| 11/19/2021 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,600 shares
@ $0 |
|
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2019 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 55,000 options to buy
@ $12.02, valued at
$661.1k
|
|
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |